Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Organigram Global Inc.NASDAQ: OGI

Gross Profit · Q2 FY2026 · quarter ended Mar 2026

Gross profit dips below year-ago levels

Q2 FY2026 gross profit of CA$16.41M fell 10.9% year over year, behind the +54.0% change in trailing-twelve-month gross profit. Sequentially, it fell 29.6% from the prior quarter.

Context

  • Gross profit amounted to 3.7% of revenue in FY2025, down 26.1 pp from a year earlier.
  • Gross profit increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -10.9% toward the trailing-twelve-month pace of +54.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$16.41M-29.6% QoQ
Last fiscal yearSep 2025
CA$6.83M-85.6% YoY
LTMMar 2026
CA$97.71M+54.0% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-10.9%——
1 year-85.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Gross Profit history

CAD · from the income statement

Latest · FY2025
6.83M CAD
Year-over-year change
-85.6%

Gross Profit vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +54.0% is the 3rd highest of 9, against a peer median of +9.1%.
  • Gross profit amounts to 35.6% of revenue for OGI, versus a peer median of 60.4%.
OGI Competitors
Gross Profit for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACBAurora Cannabis Inc.LTM Mar 2026CA$176.08M CAD-6.1%+4.2%56.6%
OGIOrganigram Global Inc.LTM Mar 2026CA$97.71M CAD+54.0%—35.6%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$80.81M USD+10.6%+9.9%56.7%
ELMDElectromed, Inc.LTM Mar 2026$56.28M USD+18.1%+16.7%78.4%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$42.13M USD—+1.0%31.2%
DERMJourney Medical CorporationLTM Mar 2026$39.07M USD+7.6%-5.1%60.4%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$32.49M USD+1115.8%+118.1%99.3%
HSDTSolana CompanyLTM Mar 2026$9.03M USD+6284.9%+157.3%94.2%
IVAInventiva S.A.FY2025€1.51M EUR-83.6%-55.4%33.7%
RNACCartesian Therapeutics, Inc.LTM Mar 2026-$11.02M USD-132.3%-70.5%621.0%
Peer median (excluding OGI) —+9.1%+4.2%60.4%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M186.09M
Cost of Revenue107.56M114.24M114.13M112.32M179.26M
Gross Profit(28.4M)31.57M35.07M47.52M6.83M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.47M59.21M71.68M68.14M86.88M
Operating Expenses63.42M74.72M271.48M83.2M70.24M
Depreciation & Amortization31.03M24.91M23.43M12.08M12.91M
EBITDA(96.71M)10.97M(25.37M)(23.59M)(14.76M)
EBITDA Margin-122.2%7.5%-17.0%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(63.41M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M0825.7K
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M(184.21M)(9.77M)35.74M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(27.66M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)0(9.89M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(17.78M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.14)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.14)
Weighted Avg Shares64.03M80.01M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M85.3M81.29M95.29M127.67M

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.